Uterine Cancer
A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma (ZN-c3-004 | GOG 3065)
- Details
ClinicalTrials.gov ID:
NCT04814108
Diagnosis Type:
NA
USOR Number:
- Address
,
P: